Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
May 23 2024 - 4:05PM
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim
Green, Chairman and Chief Executive Officer, and Jennifer Cote,
Chief Financial Officer, will be presenting to investors at the
Jefferies Global Healthcare Conference at the Marriott Marquis in
New York City on June 5, 2024.
The Company’s presentation will be 2:00-2:25 PM
ET on June 5th. The presentation will be webcast live and can be
accessed through the investor relations section of the Harvard
Bioscience website at https://investor.harvardbioscience.com. A
replay will be available shortly after the presentation has
concluded.
Harvard Bioscience will also host one-on-one
meetings with investors in conjunction with the Conference. To
schedule a one-on-one meeting, please contact
healthcareconference@jefferies.com.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a leading developer,
manufacturer and seller of technologies, products and services that
enable fundamental advances in life science applications, including
research, pharmaceutical and therapy discovery, bio-production and
preclinical testing for pharmaceutical and therapy development. Our
customers range from renowned academic institutions and government
laboratories to the world’s leading pharmaceutical, biotechnology
and contract research organizations. With operations in North
America, Europe, and China, we sell through a combination of direct
and distribution channels to customers around the
world.
For more information, please visit our website
atwww.harvardbioscience.com
Company Contact:
Harvard BioscienceJennifer Cote, Chief Financial
Officer(508) 893-3120
Investor Contacts:
Three Part AdvisorsSandy Martin / Erol Girgin / William
ShelmireHBIO@threepa.com(214) 616-2207
Harvard Bioscience (NASDAQ:HBIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Harvard Bioscience (NASDAQ:HBIO)
Historical Stock Chart
From Sep 2023 to Sep 2024